Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
605.00    -8.00 (-1.31%)
Bid:
604.00
Ask:
606.00
Spread: 2.00 (0.331%)
Market Cap: £671.40m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Directorate Changes

25 Jun 2021 07:00

RNS Number : 0647D
Barr(A.G.) PLC
25 June 2021
 

25 June 2021

 

 

A.G. BARR p.l.c.Directorate Changes 

 

BOARD APPOINTMENTS - CHAIRMAN AND NON-EXECUTIVE DIRECTOR SUCCESSION

 

A.G. BARR p.l.c. ("the Company"), the branded drinks group, is pleased to announce the following planned changes to its Board.

 

Mark Allen OBE has been appointed as an independent Non-Executive Director and Chairman designate with effect from 1 July 2021, succeeding John Nicolson as Chairman. John will step down from the Board prior to the next AGM in May 2022, following nine years as a Non-Executive Director of the Company, seven of which have been as Chairman.

 

Mark is a highly experienced director and board member with a long and successful career across multiple sectors.

 

Mark's early career in the police force sparked an interest in law and, after completing a law degree, he subsequently held a variety of corporate roles, initially with Shell Group and lately with Dairy Crest Group p.l.c. where he was CEO from 2007 to 2019, prior to the business being acquired by Saputo. In addition, Mark has held Non-Executive roles at Howden Joinery Group p.l.c., Dairy UK and Warburtons, as well as Norcros p.l.c. where he was Chair from July 2020 until April 2021. He is currently Non-Executive Chairman of Halo Foods Ltd.

 

Mark brings a deep understanding of consumer goods to the Board, as well as significant public company experience, all of which will be important as A.G. Barr continues to execute its strategy and growth plans.

 

The Company is also pleased to announce that Zoe Howorth will join the Board as a Non-Executive Director, with effect from 1 July 2021.

 

An economics graduate, Zoe has had a successful career spanning a range of roles at Procter & Gamble, United Biscuits and The Coca-Cola Company, where she spent 16 years, culminating in her role as UK Marketing Director from 2010 - 2013. Zoe has also held a number of Non-Executive Director roles with private companies and is currently a Non-Executive Director at Water Babies International. Zoe brings extensive FMCG experience, specifically across the food and beverage sector, as well as consumer brand marketing expertise and direct to consumer digital capabilities.

 

As part of her responsibilities, Zoe will Chair the Board's Environmental, Social and Governance Committee.

 

Having completed eight years as a Non-Executive Director, Pam Powell will stand down from the Board at the end of June 2021 as part of the long term Board succession plan.

 

John Nicolson, Chairman of A.G. Barr p.l.c., commented :

 

"I would personally like to thank Pam Powell for her valuable contribution over the past eight years in helping to shape the direction and performance of the business.

 

"I am delighted that both Mark and Zoe will be joining our Board, both of whom bring a wealth of highly relevant experience and I look forward to welcoming them at this exciting time for AG Barr."

 

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Mark Allen or Zoe Howorth's appointments as Non-Executive Directors of the Company.

 

 

For more information, please contact :

 

A.G. BARR Instinctif Partners

0330 390 3900 020 7457 2010/05

Roger White, Chief Executive Justine Warren

Deborah Jones, Head of Corporate Affairs and Comms. Matthew Smallwood

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEAFILEFSEIM
Date   Source Headline
10th Feb 20253:59 pmRNSDirector/PDMR Shareholding - Replacement
10th Feb 20253:10 pmRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSTrading Update
20th Jan 202511:00 amRNSDirector Declaration
9th Jan 20254:42 pmRNSDirector/PDMR Shareholding
7th Jan 202511:44 amRNSNotice of Trading Update
17th Dec 20249:20 amRNSDirector Declaration
9th Dec 20241:50 pmRNSDirector/PDMR Shareholding
12th Nov 20241:35 pmRNSDirector/PDMR Shareholding
4th Nov 202410:54 amRNSDirector/PDMR Shareholding
9th Oct 202410:10 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSInterim Results
9th Sep 20241:03 pmRNSDirector/PDMR Shareholding
4th Sep 20249:08 amRNSDirector Declaration
20th Aug 20248:39 amRNSDirector/PDMR Shareholding
8th Aug 20241:10 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTrading Statement
8th Jul 202412:03 pmRNSDirector/PDMR Shareholding
4th Jul 202410:17 amRNSNotice of Results
1st Jul 20244:50 pmRNSDirector/PDMR Shareholding
21st Jun 20243:22 pmRNSDirector/PDMR Shareholding
10th Jun 20241:51 pmRNSDirector/PDMR Shareholding
10th Jun 20241:48 pmRNSDirector/PDMR Shareholding
4th Jun 20249:36 amRNSDirector/PDMR Shareholding
31st May 20241:54 pmRNSResult of AGM
9th May 202411:28 amRNSDirector/PDMR Shareholding
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.